Radiolabeled LHRH and FSH Analogues as Cancer Theranostic Agents: A Systematic Review. [PDF]
Giorgio A +4 more
europepmc +1 more source
ARTnet Perspectives and Contributions to Theranostics. [PDF]
Francis RJ +8 more
europepmc +1 more source
Comparison of [68Ga]Ga-Fibroblast Activation Protein Inhibitor–04 and [18F]FDG PET Imaging for Solitary Fibrous Tumor and Preliminary Application of FAP-Targeted Radiopharmaceutical Therapy [PDF]
Rongxi Wang +9 more
openalex +1 more source
Streamlining first-in-human PET radiopharmaceutical development: FDA's evolving stance on preclinical dosimetry. [PDF]
Zhao T, Liang SH.
europepmc +1 more source
Determination Of Myocardial Function Using Heart Accumulated Radiopharmaceuticals
C. C. D. Kulathilake +2 more
openalex +1 more source
UAB/SNMMI Nuclear Medicine Therapy Intensive: Advancing Competence and Innovation in Radiopharmaceutical Therapy. [PDF]
Glasgow KW, Brady AB.
europepmc +1 more source
Molecular targets and the emerging role of copper radionuclides in prostate cancer theranostics. [PDF]
Rodrigues D +4 more
europepmc +1 more source
Implementation of automated radiopharmaceutical dispenser with integrated radiation shielding
Somsakul Thumvijit, Winit Choiprasert
openalex +1 more source
Radioligand Therapy in Cancer Management: A Global Perspective. [PDF]
Ninatti G, Lee ST, Scott AM.
europepmc +1 more source
Preclinical PET and SPECT Imaging in Small Animals: Technologies, Challenges and Translational Impact. [PDF]
Bruzgo-Grzybko M +5 more
europepmc +1 more source

